native med tirzepatide Tirzepatide: Injection Home Kit – NativeMed Tirzepatide

If you'd rather watch than read, check out the video below

We work with many major insurance plans, ensuring your coverage aligns with your treatment

As far as we are aware, ongoing clinical trials are mainly looking at the effects of SGLT2 inhibitors in obese subjects without diabetes as a monotherapy (NCT03710460

Semaglutide belongs to a broader class of medications known as GLP-1 receptor agonists, which are used to treat obesity and type 2 diabetes. Semaglutides act like the glucagon-like peptide-1 (GLP-1) hormone our bodies make, which is released from our gut after we eat, explains Jessica Duncan, MD, DABOM, DABA, chief medical officer at Ivim Health